Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Trump and Xi meet in Busan, signaling progress in US-China trade talks and a mutual desire to stabilize their complex economic relationship.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.
Global tech stocks show mixed performance as investors navigate economic uncertainties, focusing on companies with solid fundamentals and emerging technology trends.
Trump and Xi meet in Busan, signaling progress in US-China trade talks and a mutual desire to stabilize their complex economic relationship.
Novo Nordisk launches $9B bid to acquire U.S. obesity biotech Metsera, intensifying the race for next-generation weight-loss treatments.